Figure 4
From: IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients

Actuarial 2 year nodal disease free survival according to N stages (N0 patients remain nodally controlled)
From: IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients
Actuarial 2 year nodal disease free survival according to N stages (N0 patients remain nodally controlled)